Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 4/20 | 0.39 |
| ▸ | RNPEP | Q9H4A4 | 3/20 | 0.39 |
| ▸ | DNPEP | Q9ULA0 | 3/20 | 0.39 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.33 |
| ▸ | GABRP | O00591 | 2/20 | 0.32 |
| ▸ | GABRD | O14764 | 2/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.32 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.32 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.32 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.32 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.32 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.32 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.32 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.32 |
| ▸ | GABRE | P78334 | 2/20 | 0.32 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.32 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.32 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.32 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12132309 | 1.00 | ANPEP (0.39) | ANPEPRNPEPDNPEPDPP7GABRP | |
| SCHEMBL13363467 | 1.00 | ANPEP (0.39) | ANPEPRNPEPDNPEPDPP7GABRP | |
| SCHEMBL10046218 | 0.89 | DPP7 (0.41) | ANPEPRNPEPDNPEPDPP7NPY4R | |
| SCHEMBL10046217 | 0.89 | DPP7 (0.41) | ANPEPRNPEPDNPEPDPP7NPY4R | |
| SCHEMBL16488995 | 0.89 | DPP7 (0.41) | ANPEPRNPEPDNPEPDPP7NPY4R | |
| SCHEMBL13300735 | 0.88 | DPP7 (0.44) | ANPEPRNPEPDNPEPDPP7NPY4R | |
| SCHEMBL22387177 | 0.88 | DPP7 (0.44) | ANPEPRNPEPDNPEPDPP7NPY4R | |
| SCHEMBL23988728 | 0.86 | GNAI3 (0.44) | ANPEPRNPEPDNPEPDPP7NPY4R | |
| SCHEMBL26605966 | 0.86 | ANPEP (0.37) | ANPEPRNPEPDNPEPDPP7NPY4R | |
| SCHEMBL20388782 | 0.85 | ANPEP (0.31) | ANPEPRNPEPDNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230227420-A1 | PRODRUGS OF MDMA, MDA, AND DERIVATIVES THEREOF | EMPATHBIO, INC. | 2023-07-20 | — | — | US | disclosed |
| WO-2023056102-A1 | NOVEL PRODRUGS OF MDMA, MDA, AND DERIVATIVES THEREOF | ATAI Life Sciences AG (DE) | 2023-04-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230227420-A1 | PRODRUGS OF MDMA, MDA, AND DERIVATIVES THEREOF | COMT, PNMT, ABCB1 | ANPEP 642/4885RNPEP 1484/4885DNPEP 270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.